Managed Care Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hospira, Inc.
First orders of ceftriaxone injection shipped
August 16th, 2005
Hospira, Inc., (HSP) announced that it has shipped the first customer orders of the company's generic ceftriaxone for injection, USP. The medication is the generic version of Roche Pharmaceuticals' Rocephin, an injectable antibiotic, which posted 2004 U.S. sales of more than $650 million. Ceftriaxone is commonly used as a first line agent against a wide range of acute infections, such as community-acquired pneumonia, and is available from Hospira in a full range of vials - including the proprietary ADD-Vantage system. "Hospira is offering generic ceftriaxone in a broad array of delivery options, positioning us to help hospitals reduce costs when...
Source: Managed Care Business Week (2005-08-16)
|
